ArticleJournal of thoracic disease2025

Exacerbation control in chronic obstructive pulmonary disease with tezepelumab: insights from the COURSE trial.

Dil Afrose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.